• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Trendingnow

1

Now worth $200 million, Sarah Jessica Parker credits being ‘one of eight kids that struggled financially’ for her hunger, ambition, and work ethic

2

The Pentagon said Iran War costs $29 billion, but the real cost is closer to $200 billion—and counting

3

After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cup

1

Now worth $200 million, Sarah Jessica Parker credits being ‘one of eight kids that struggled financially’ for her hunger, ambition, and work ethic

2

The Pentagon said Iran War costs $29 billion, but the real cost is closer to $200 billion—and counting

3

After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cup
LeadershipMonsanto

U.S. Scientists to Skip Monsanto Summit on Controversial Weed Killer

By
Reuters
Reuters
Down Arrow Button Icon
By
Reuters
Reuters
Down Arrow Button Icon
September 26, 2017, 10:37 PM ET
MISSISSIPPI COUNTY, AR - August 9, 2017: Brian Smith and his co
MISSISSIPPI COUNTY, AR - August 9, 2017: Brian Smith and his cousin Hughes, both fifth generation soybean farmers, stand in soybean fields their family tend to that show signs of having been affected by Dicamba use. Dicamba, a weed killer that has been used for over 50 years, is now having a devastating impact in Arkansas and neighboring states because because the Monsanto is now selling new soybean and cotton varieties that have been genetically altered to tolerate Dicamba. While Arkansas voted to put a ban in place, farmers continue finding fields bearing the effects of the herbicide.The Washington Post/Getty Images
Add Fortune on Google for similar content.

Monsanto (MON) invited dozens of weed scientists to a summit this week to win backing for a controversial herbicide but many have declined, threatening the company’s efforts to convince regulators the product is safe to use.

Monsanto faces a barrage of lawsuits over its dicamba herbicide and risks of tighter restrictions on its use, after the chemical drifted away from where it was sprayed this summer and damaged nearby crops unable to tolerate it.

Arkansas and Missouri suffered the most complaints of U.S. states with damage linked to dicamba. Weed scientists from the two states declined to attend the summit on concerns about Monsanto’s response to the incident.

The company plans to present data at the summit that it says show user error was behind the damage, contrary to academics’ findings that dicamba products can vaporize and move off target under certain conditions in a process known as volatilization.

Missing will be Kevin Bradley, a University of Missouri plant sciences professor who has tracked the number of crop acres nationwide that have been hurt by dicamba sprayings. Bradley said he believed Monsanto was not willing to discuss volatilization.

“I think it’s best for me to stay away from that,” he said.

To prevent damage next year, states and the U.S. Environmental Protection Agency (EPA) are considering new rules for usage, decisions to be based partly on advice from university weed scientists invited to the meeting, whether they attend or not.

Tighter restrictions could hurt sales of the herbicide or of Monsanto soybean seeds engineered to resist the chemical, the company’s biggest ever biotech seed launch.

Arkansas on Thursday moved just one step away from barring sprayings of dicamba next summer, setting the stage for a potential legal showdown with Monsanto.

Time is now of the essence as farmers start to make planting decisions for next spring.

The EPA has held calls with university weed experts to discuss potential regulations.

For more on Monsanto, watch Fortune’s video:

BASF SE, which also sells a dicamba-based weed killer, has invited scientists to its own meeting on the herbicide. The American Soybean Association, which represents farmers, is convening a meeting, too.

Monsanto’s summit, to be held near the company’s headquarters in St. Louis, will be the largest meeting so far on dicamba, said Scott Partridge, the company’s vice president of global strategy. At least half of about 60 invitees will attend and hear presentations from Monsanto and outside experts, he said.

Reuters contacted 10 scientists who were invited. Of these, three said they would attend and seven said they would not, for reasons including scheduling conflicts.

“We want them to challenge us and we intend to challenge those who are presenting data,” Partridge said.

INTEGRITY QUESTIONED

Monsanto recently upset U.S. weed scientists by questioning the objectivity of two Arkansas experts, Jason Norsworthy and Ford Baldwin, who said dicamba had problems with volatilization. The specialists could be biased against the chemical because they were affiliated with Bayer AG, which sells a competing system to control weeds in soybeans, according to Monsanto.

Norsworthy, a University of Arkansas professor, has declined an invitation to speak about volatilization at Monsanto’s meeting, according to the university. Last year, the EPA cited his research on the best way to use dicamba when the agency approved the use of the chemical on crops that can resist it.

Two other University of Arkansas experts, Tom Barber and Bob Scott, will also not attend.

“With Monsanto questioning of the integrity of our science, we felt it was best not to participate,” university spokeswoman Mary Hightower said.

Monsanto highlighted connections Norsworthy and Baldwin had to Bayer to ensure that Arkansas fairly reviewed dicamba, Partridge said.

In July, Arkansas banned dicamba use for 120 days.

MONSANTO MONOLOGUE?

Monsanto’s critiques of experts follows past accusations by farmers and activists that the company improperly influenced science.

In March, farmers and others suing Monsanto claimed in court filings that Monsanto employees ghostwrote scientific reports that U.S. regulators relied on to determine that glyphosate, a chemical in its Roundup weed killer, did not cause cancer.

In 2015, the New York Times reported U.S. academics who received grants from Monsanto were used in lobbying and corporate public relations campaigns to defend the safety of genetically engineered food.

Monsanto will cover travel costs for academics who attend this week’s meeting, as is customary for the company, spokeswoman Charla Lord said.

Among those attending will be University of Tennessee weed scientist Tom Mueller, who told Reuters he planned to pay his own way and was skeptical Monsanto would engage in discussions.

“I think it’s just going to be a monolog,” he said.

Mueller said U.S. weed scientists had discussed skipping the meeting because they were upset Monsanto had criticized the Arkansas scientists.

“There’s some pretty strong sentiment that some states won’t send anybody,” he said. Reuters did not confirm that any states would have no representatives at the meeting.

About the Author
By Reuters
See full bioRight Arrow Button Icon
Add Fortune on Google for similar content.

Latest in Leadership

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Leadership

Ikea’s billionaire founder was so frugal that he bought clothes from flea markets and took free salt and pepper from restaurants
SuccessBillionaires
Ikea’s billionaire founder was so frugal that he bought clothes from flea markets and took free salt and pepper from restaurants
By Orianna Rosa RoyleJune 25, 2026
2 hours ago
Fortune 500 bosses demanding staff return to the office share one trait: narcissism, research finds
C-SuiteLeadership
Fortune 500 bosses demanding staff return to the office share one trait: narcissism, research finds
By Claire ZillmanJune 25, 2026
2 hours ago
MacKenzie Scott alone accounted for one-third of America’s $19.2 billion in megagifts last year
SuccessMacKenzie Scott
MacKenzie Scott alone accounted for one-third of America’s $19.2 billion in megagifts last year
By Sydney LakeJune 25, 2026
2 hours ago
A college graduate in regalia rests his chin in his hand.
Future of WorkGen Z
Gen Z graduates are blaming AI for their unemployment woes when they should be looking somewhere else
By Sasha RogelbergJune 25, 2026
2 hours ago
Getting past the pilot: Why so many AI test projects have trouble scaling
SuccessBrainstorm Tech
Getting past the pilot: Why so many AI test projects have trouble scaling
By Alexei OreskovicJune 24, 2026
10 hours ago
How ‘Ozempic face’ is pushing Gen X, already the biggest Botox and filler consumers, to the facelift table a decade early
HealthGen X
How ‘Ozempic face’ is pushing Gen X, already the biggest Botox and filler consumers, to the facelift table a decade early
By Mia OsmonbekovJune 24, 2026
12 hours ago

Most Popular

Now worth $200 million, Sarah Jessica Parker credits being ‘one of eight kids that struggled financially’ for her hunger, ambition, and work ethic
Success
Now worth $200 million, Sarah Jessica Parker credits being ‘one of eight kids that struggled financially’ for her hunger, ambition, and work ethic
By Orianna Rosa RoyleJune 24, 2026
1 day ago
The Pentagon said Iran War costs $29 billion, but the real cost is closer to $200 billion—and counting
Economy
The Pentagon said Iran War costs $29 billion, but the real cost is closer to $200 billion—and counting
By Jacqueline MunisJune 24, 2026
1 day ago
After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cup
Success
After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cup
By Orianna Rosa RoyleJune 23, 2026
2 days ago
Amazon's record Prime Day masks a darker truth: Americans are spending more and getting less
Retail
Amazon's record Prime Day masks a darker truth: Americans are spending more and getting less
By Nick LichtenbergJune 24, 2026
18 hours ago
Ray Dalio just finished a 10-day trip to China. He says global leaders know America ‘doesn’t have what it takes to fight to maintain its empire’
Asia
Ray Dalio just finished a 10-day trip to China. He says global leaders know America ‘doesn’t have what it takes to fight to maintain its empire’
By Nick LichtenbergJune 24, 2026
20 hours ago
Trump’s international student crackdown kicked off a domino effect that could shave nearly $500 billion off the economy
Economy
Trump’s international student crackdown kicked off a domino effect that could shave nearly $500 billion off the economy
By Tristan BoveJune 24, 2026
15 hours ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.